Publication Feature: Decentralized Trials in the Age of Real-World Evidence and Inclusivity in Clinical Investigations

May 2019

This review, published in Clinical Pharmacology & Therapeutics, discusses considerations for decentralized clinical trials and how they can extend the reach of clinical investigations to historically underserved populations. The authors are Andy Coravos, Research Collaborator at the Harvard-MIT CRS, and Sean Khozin, Director of FDA INFORMED. Learn more here.